Happy news: @juliencsenecal completed a stellar PhD defence, earning his OFK Lab coveralls! This amazing engineer's PhD highlights include patents, papers, a book chapter and a startup. I'm so proud! Julien, thank you for sharing these past 5 years with me and the Blue Coats 🎉

What happens when you merge ionizable lipid design with supramolecular chemistry? Great RNA nanoparticles with thermostability! Read about our supramolecular ionizable lipid in the latest paper from Alanna M. Manning and the #OFKLabBlueCoats onlinelibrary.wiley.com/doi/… @AdvSciNews

Following a great Montreal conference for the #OFKLabBlueCoats, Professor Khan presented at this year’s Canadian Chemistry Conference and Exhibition (CSC 2023) on Vancouver’s beautiful waterfront! It’s been a great summer for connecting with Canada’s scientific community!

To mark World AIDS day, reporter @manesa_d discussed the current state of HIV vaccines & therapies. To equitably address the 2 types of HIV that affect different parts of the world, the R&D community continues their work to create solutions for both. 👉🔗youtu.be/KHAnUmVJQRM

.@globalnews' @JamieMauracher discusses 4th vaccine doses this fall with the original or bivalent vaccines. With BA.4 and BA.5 on the rise, any boost helps. Thanks for the chance to contribute. 👉globalnews.ca/video/8960565/… @bme_uoft @uoftengineering @MbD_UofT @CRC_CRC @CRSNG_NSERC

Looking forward to giving an invited talk in the gene therapy session of the 37th Annual Meeting of the Canadian Biomaterials Society (@CanBiomatSoc) in a few minutes! Thanks to @bme_uoft @uoftengineering @CRC_CRC @MbD_UofT @UofTPRiME @CRSNG_NSERC for supporting our research!

.@globalnewsto's @JamieMauracher discusses how a nasal vaccine can improve mucosal immunity via pathogen-specific IgA antibodies. Thanks for the opportunity to contribute. Link to the story: globalnews.ca/video/rd/e1b4d… @bme_uoft @uoftengineering @CRC_CRC @MbD_UofT @UofTPRiME

Thanks to @ctvnewschannel's @LoisLeeTV @avcrayton @Jared_Lalondefor for discussing Health Canada's review of Moderna's pediatric COVID-19 vaccine application, safety in kids & how in-trial omicron-focused updates can help.@bme_uoft @uoftengineering @CRC_CRC @MbD_UofT @UofTPRiME

The #OFKLabBlueCoats working hard to bridge the translation gap through applied science and engineering 🧪🔬💻⚙️🔧 @bme_uoft @uoftengineering @MbD_UofT @UofTPRiME @CRC_CRC

Thanks @CBCTheNational @FarrahMerali for discussing how hospitalization, case & testing numbers will inform policy updates for Omicron BA.2. Long term stability is easier with global vax outreach. 🔗gem.cbc.ca/media/the-nationa… @bme_uoft @uoftengineering @MbD_UofT @UofTPRiME @CRC_CRC

Moderna's vaccine appears to protect 0.5-6 years olds against severe disease from Omicron. Regulators to examine the data before approval. Thanks to @CityNewsTO's @shaunacitynews for discussing.👉🏾🔗 toronto.citynews.ca/video/20… @bme_uoft @uoftengineering @MbD_UofT @UofTPRiME @CRC_CRC

Thanks to @globalnewsto's @JamieMauracher for discussing future COVID-19 vaccines. Omicron-specific ones are now in trials but a 4th dose of our existing vaccine may help with a sudden surge. Link: globalnews.ca/video/rd/19fad… @bme_uoft @CRC_CRC @uoftengineering @MbD_UofT @UofTPRiME

Thanks @globalnews' @katrinasquazzin for discussing the risk factors (e.g. changes to disease severity with new mutations, hospitalizations & updated vaccine availability) that are considered when updating COVID policies. @bme_uoft @MbD_UofT @UofTPRiME @CRC_CRC @uoftengineering